rs377692278

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001009944.3(PKD1):​c.11538-11C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00181 in 1,560,680 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0014 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0019 ( 3 hom. )

Consequence

PKD1
NM_001009944.3 intron

Scores

2
Splicing: ADA: 0.00005669
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.153

Publications

0 publications found
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
PKD1-AS1 (HGNC:56035): (PKD1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 16-2091608-G-A is Benign according to our data. Variant chr16-2091608-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 256905.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00135 (206/152200) while in subpopulation AMR AF = 0.00203 (31/15302). AF 95% confidence interval is 0.00167. There are 1 homozygotes in GnomAd4. There are 95 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKD1NM_001009944.3 linkc.11538-11C>T intron_variant Intron 41 of 45 ENST00000262304.9 NP_001009944.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKD1ENST00000262304.9 linkc.11538-11C>T intron_variant Intron 41 of 45 1 NM_001009944.3 ENSP00000262304.4 P98161-1

Frequencies

GnomAD3 genomes
AF:
0.00135
AC:
206
AN:
152082
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000869
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00203
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00194
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00152
AC:
261
AN:
172118
AF XY:
0.00158
show subpopulations
Gnomad AFR exome
AF:
0.000511
Gnomad AMR exome
AF:
0.000884
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000696
Gnomad FIN exome
AF:
0.000981
Gnomad NFE exome
AF:
0.00273
Gnomad OTH exome
AF:
0.00172
GnomAD4 exome
AF:
0.00186
AC:
2617
AN:
1408480
Hom.:
3
Cov.:
32
AF XY:
0.00182
AC XY:
1267
AN XY:
697176
show subpopulations
African (AFR)
AF:
0.000368
AC:
12
AN:
32588
American (AMR)
AF:
0.000809
AC:
32
AN:
39548
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24880
East Asian (EAS)
AF:
0.0000527
AC:
2
AN:
37952
South Asian (SAS)
AF:
0.000690
AC:
56
AN:
81188
European-Finnish (FIN)
AF:
0.00108
AC:
38
AN:
35314
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4940
European-Non Finnish (NFE)
AF:
0.00219
AC:
2395
AN:
1093462
Other (OTH)
AF:
0.00140
AC:
82
AN:
58608
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
125
250
375
500
625
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00135
AC:
206
AN:
152200
Hom.:
1
Cov.:
33
AF XY:
0.00128
AC XY:
95
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.000866
AC:
36
AN:
41550
American (AMR)
AF:
0.00203
AC:
31
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5172
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4830
European-Finnish (FIN)
AF:
0.000283
AC:
3
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00194
AC:
132
AN:
67948
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
10
20
31
41
51
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00146
Hom.:
0
Bravo
AF:
0.00140

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
May 25, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Polycystic kidney disease, adult type Benign:2
Aug 03, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 06, 2019
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Polycystic kidney disease Benign:1
-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

The PKD1 c.11538-11C>T variant was identified in 5 of 916 proband chromosomes (frequency: 0.005) from French and North American individuals or families with ADPKD (Garcia-Gonzalez 2007, Perrichot 1999, Rossetti 2012). The variant was also identified in dbSNP (ID: rs377692278) “With Likely benign allele”, ClinVar (classified likely benign by Prevention Genetics), and ADPKD Mutation Database (as likely neutral), but was not identified in COGR, and PKD1-LOVD databases. The variant was identified in control databases in 286 of 199042 chromosomes at a frequency of 0.001 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Consortium Feb 27, 2017). Breakdown of the observations by population include African in 8 of 18176 chromosomes (freq: 0.0004), European Non-Finnish in 223 of 188344 chromosomes (freq: 0.003), South Asian in 9 of 24676 chromosomes (freq: 0.0004), Other in 8 of 5104 chromosomes (freq: 0.002), Latino in 26 of 28456 chromosomes (freq: 0.0009), East Asian in 1 of 15360 chromosomes (freq: 0.00007), and European Finnish in 11 of 10842 chromosomes (freq: 0.001); it was not observed in the Ashkenazi Jewish population. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. -

not provided Benign:1
Apr 19, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 10987650, 22383692, 17574468) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
8.0
DANN
Benign
0.77
PhyloP100
0.15
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000057
dbscSNV1_RF
Benign
0.0040
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs377692278; hg19: chr16-2141609; API